Pulmonologists' Attitudes and Role in Precision Medicine Biomarker Testing for Non-Small Cell Lung Cancer.

ABSTRACT:

Background

Despite advances in precision medicine for non-small cell lung cancer (NSCLC), biomarker testing for these therapies remains frequently underused, delayed, and inequitable. Pulmonologists often play a critical role in the initial diagnostic steps for patients with lung cancer, and previous data show variability in their knowledge and practices regarding biomarker testing. The purpose of this study is to better understand how pulmonologists view their role in lung cancer care.

Research question

With the increasing importance of biomarker testing and precision medicine, how do pulmonologists view their role in lung cancer care?

Study design

An electronic survey consisting of 31 items focused on attitudes and practices regarding diagnostic steps for NSCLC was

SUBMITTER: Fox AH 

PROVIDER: S-EPMC12087638 | biostudies-literature | 2024 Nov

REPOSITORIES: biostudies-literature